المؤلفون: Varvarà P; Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo, Via Archirafi 32, Palermo 90123, Italy; Fondazione Veronesi, Piazza Velasca 5, 20122 Milano, Italy., Emanuele Drago S; Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo, Via Archirafi 32, Palermo 90123, Italy., Esposito E; Dipartimento Di Scienze Chimiche, Biologiche, farmaceutiche ed Ambientali (CHIBIOFARAM), via F. Stagno d'Alcontres 31, università degli Studi di Messina, Messina 98165, Italy., Campolo M; Dipartimento Di Scienze Chimiche, Biologiche, farmaceutiche ed Ambientali (CHIBIOFARAM), via F. Stagno d'Alcontres 31, università degli Studi di Messina, Messina 98165, Italy., Mauro N; Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo, Via Archirafi 32, Palermo 90123, Italy., Calabrese G; Dipartimento Di Scienze Chimiche, Biologiche, farmaceutiche ed Ambientali (CHIBIOFARAM), via F. Stagno d'Alcontres 31, università degli Studi di Messina, Messina 98165, Italy., Conoci S; Dipartimento Di Scienze Chimiche, Biologiche, farmaceutiche ed Ambientali (CHIBIOFARAM), via F. Stagno d'Alcontres 31, università degli Studi di Messina, Messina 98165, Italy; Dipartimento di Chimica 'Giacomo Ciamician', Alma Mater Studiorum, Università di Bologna, Italy; LAB Sense Beyond Nano-URT Department of Sciences Physics and Technologies of Matter (DSFTM) CNR, Messina 98166, Italy., Morganti D; LAB Sense Beyond Nano-URT Department of Sciences Physics and Technologies of Matter (DSFTM) CNR, Messina 98166, Italy., Fazio B; LAB Sense Beyond Nano-URT Department of Sciences Physics and Technologies of Matter (DSFTM) CNR, Messina 98166, Italy., Giammona G; Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo, Via Archirafi 32, Palermo 90123, Italy., Pitarresi G; Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche (STEBICEF), Università degli Studi di Palermo, Via Archirafi 32, Palermo 90123, Italy. Electronic address: giovanna.pitarresi@unipa.it.

المصدر: International journal of pharmaceutics [Int J Pharm] 2024 Sep 05; Vol. 662, pp. 124537. Date of Electronic Publication: 2024 Jul 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3476 (Electronic) Linking ISSN: 03785173 NLM ISO Abbreviation: Int J Pharm Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Hepatocellular*/drug therapy , Carcinoma, Hepatocellular*/pathology , Phenylurea Compounds*/administration & dosage , Phenylurea Compounds*/pharmacokinetics , Phenylurea Compounds*/chemistry , Liver Neoplasms*/drug therapy , Liver Neoplasms*/pathology , Mice, Nude* , Quinolines*/administration & dosage , Quinolines*/chemistry , Quinolines*/pharmacokinetics , Nanoparticles*/chemistry , Antineoplastic Agents*/administration & dosage , Antineoplastic Agents*/chemistry , Antineoplastic Agents*/pharmacokinetics , Antineoplastic Agents*/pharmacology, Animals ; Humans ; Tissue Distribution ; Cell Line, Tumor ; Drug Delivery Systems ; Xenograft Model Antitumor Assays ; Drug Liberation ; Mice ; Biotinylation ; Mice, Inbred BALB C ; Drug Carriers/chemistry ; Apoptosis/drug effects ; Polymers/chemistry

المؤلفون: French JD; Division of Endocrinology, Metabolism, and Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado.; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.; University of Colorado Cancer Center, Aurora, Colorado., Haugen BR; Division of Endocrinology, Metabolism, and Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado.; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado.; University of Colorado Cancer Center, Aurora, Colorado., Worden FP; Department of Medicine, University of Michigan, Rogel Cancer Center, Ann Arbor, Michigan., Bowles DW; University of Colorado Cancer Center, Aurora, Colorado.; Division of Medical Oncology, University of Colorado Denver, Aurora, Colorado.; Department of Medicine, University of Colorado Denver, Aurora, Colorado., Gianoukakis AG; David Geffen School of Medicine at UCLA, Los Angeles, California.; Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California., Konda B; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Dadu R; Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sherman EJ; David H. Koch Center for Cancer Care, Memorial Slone Kettering Cancer Center, New York, New York., McCue S; Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota., Foster NR; Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, Minnesota., Nikiforov YE; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Farias TDJ; Department of Biomedical Informatics, University of Colorado School of Medicine, Aurora, Colorado., Norman PJ; Department of Biomedical Informatics, University of Colorado School of Medicine, Aurora, Colorado.; Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, Colorado., Wirth LJ; Massachusetts General Hospital, Boston, Massachusetts.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 03; Vol. 30 (17), pp. 3757-3767.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Quinolines*/administration & dosage , Quinolines*/therapeutic use , Quinolines*/adverse effects , Phenylurea Compounds*/administration & dosage , Phenylurea Compounds*/therapeutic use , Phenylurea Compounds*/adverse effects , Thyroid Neoplasms*/drug therapy , Thyroid Neoplasms*/pathology , Thyroid Neoplasms*/mortality , Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/adverse effects , Iodine Radioisotopes*/therapeutic use , Iodine Radioisotopes*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects, Humans ; Female ; Male ; Middle Aged ; Aged ; Adult ; Protein Kinase Inhibitors/therapeutic use ; Protein Kinase Inhibitors/administration & dosage ; Protein Kinase Inhibitors/adverse effects ; Aged, 80 and over

المؤلفون: Lv Z; State Key Laboratory of Virology, Department of Medical Microbiology, School of Basic Medical Sciences, Wuhan University, Wuhan, China., Liu L; State Key Laboratory of Virology, Department of Medical Microbiology, School of Basic Medical Sciences, Wuhan University, Wuhan, China.; Hubei Province Key Laboratory of Allergy and Immunology, Wuhan University, Wuhan, China., You J; Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, National Quality Control Center for Donated Organ Procurement, Hubei Key Laboratory of Medical Technology on Transplantation, Hubei Clinical Research Center for Natural Polymer Biological Liver, Hubei Engineering Center of Natural Polymer-based Medical Materials, Wuhan, China., Zhou P; State Key Laboratory of Virology, Department of Medical Microbiology, School of Basic Medical Sciences, Wuhan University, Wuhan, China., Su Y; State Key Laboratory of Virology, Department of Medical Microbiology, School of Basic Medical Sciences, Wuhan University, Wuhan, China., Zhao K; State Key Laboratory of Virology, Department of Medical Microbiology, School of Basic Medical Sciences, Wuhan University, Wuhan, China., Zhang J; State Key Laboratory of Virology, Department of Medical Microbiology, School of Basic Medical Sciences, Wuhan University, Wuhan, China., Zhu F; State Key Laboratory of Virology, Department of Medical Microbiology, School of Basic Medical Sciences, Wuhan University, Wuhan, China.; Hubei Province Key Laboratory of Allergy and Immunology, Wuhan University, Wuhan, China.

المصدر: Journal of medical virology [J Med Virol] 2024 Sep; Vol. 96 (9), pp. e29894.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print Cited Medium: Internet ISSN: 1096-9071 (Electronic) Linking ISSN: 01466615 NLM ISO Abbreviation: J Med Virol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Hepatocellular*/virology , Carcinoma, Hepatocellular*/drug therapy , Liver Neoplasms*/virology , Liver Neoplasms*/drug therapy , Drug Resistance, Neoplasm*/genetics , Hepatitis B Surface Antigens*/genetics , Hepatitis B Surface Antigens*/metabolism , Pyridines*/pharmacology , Pyridines*/therapeutic use , Phenylurea Compounds*/pharmacology , Phenylurea Compounds*/therapeutic use, Humans ; Animals ; Mice ; Male ; Female ; Receptors, CCR/genetics ; Receptors, CCR/metabolism ; Cell Line, Tumor ; Hepatitis B virus/genetics ; Hepatitis B virus/drug effects ; Middle Aged ; Hepatitis B/virology ; Hepatitis B/complications ; Hepatitis B/drug therapy ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Cell Proliferation/drug effects ; Adenosine/analogs & derivatives

المؤلفون: Kuang S; Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Zhang J; Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Huang N; Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Zhang J; Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Chen B; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Wang L; Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China., Liu M; Laboratory of Cell and Molecular Biology & State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

المصدر: Molecular carcinogenesis [Mol Carcinog] 2024 Sep; Vol. 63 (9), pp. 1738-1749. Date of Electronic Publication: 2024 Jun 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8811105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-2744 (Electronic) Linking ISSN: 08991987 NLM ISO Abbreviation: Mol Carcinog Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Hepatocellular*/drug therapy , Carcinoma, Hepatocellular*/pathology , Carcinoma, Hepatocellular*/radiotherapy , Carcinoma, Hepatocellular*/metabolism , Phenylurea Compounds*/pharmacology , Phenylurea Compounds*/therapeutic use , Pyridines*/pharmacology , Pyridines*/therapeutic use , Liver Neoplasms*/drug therapy , Liver Neoplasms*/pathology , Liver Neoplasms*/radiotherapy , Liver Neoplasms*/metabolism , Cell Proliferation*/drug effects , Xenograft Model Antitumor Assays* , Apoptosis*/drug effects, Animals ; Humans ; Mice ; Cell Line, Tumor ; STAT3 Transcription Factor/metabolism ; Mice, Nude ; Signal Transduction/drug effects ; Mice, Inbred BALB C ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Male ; Gene Expression Regulation, Neoplastic/drug effects

المؤلفون: Rimini M; Department of Oncology, IRCCS San Raffaele Scientific Institute Hospital, Vita-Salute San Raffaele University, Milan, Italy.; Vita-Salute University San Raffaele, Milan, Italy., Montes M; Liver Unit-CHTMAD, Vila Real, Portugal., Amadeo E; Department of Oncology, IRCCS San Raffaele Scientific Institute Hospital, Vita-Salute San Raffaele University, Milan, Italy., Vitiello F; Department of Oncology, IRCCS San Raffaele Scientific Institute Hospital, Vita-Salute San Raffaele University, Milan, Italy., Kudo M; Department of Gastroenterology and Hepatology, Faculty of Medicine, Kindai University, Higashiosaka, Japan., Tada T; Department of Internal Medicine, Japanese Red Cross Himeji Hospital, Himeji, Japan., Suda G; Department of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido University, North 15, West 7, Kita-ku, Sapporo, Hokkaido, 060-8638, Japan., Shimose S; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, 830-0011, Japan., Lonardi S; Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Finkelmeier F; Department of Internal Medicine 1, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany., Salani F; Unit of Medical Oncology 2, University Hospital of Pisa, Pisa, Italy., Antonuzzo L; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., Marra F; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy., Iavarone M; Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Cabibbo G; Section of Gastroenterology and Hepatology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, PROMISE, University of Palermo, Palermo, Italy., Foschi FG; Department of Internal Medicine, Ospedale degli Infermi di Faenza, Faenza, Emilia Romagna, Italy., Silletta M; Department of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy., Sacco R; Gastroenterology and Digestive Endoscopy Unit, Foggia University Hospital, Foggia, Puglia, Italy., Rapposelli IG; Medical Oncology Unit, IRST IRCCS, Meldola, Italy., Scartozzi M; Medical Oncology, University and University Hospital of Cagliari, Cagliari, Italy., Nicoletta P; Department of Oncology, ASUFC University Hospital, Udine, Italy., Aldrighetti L; Hepato-Biliary Surgery Department, IRCCS San Raffaele Hospital, Milan, Italy., Persano M; Medical Oncology, University and University Hospital of Cagliari, Cagliari, Italy., Camera S; Medical Oncology, University and University Hospital of Cagliari, Cagliari, Italy., Rossari F; Department of Oncology, IRCCS San Raffaele Scientific Institute Hospital, Vita-Salute San Raffaele University, Milan, Italy., Foti S; Department of Oncology, IRCCS San Raffaele Scientific Institute Hospital, Vita-Salute San Raffaele University, Milan, Italy., Kumada T; Department of Internal Medicine, Japanese Red Cross Himeji Hospital, Himeji, Japan., Hiraoka A; Department of Internal Medicine, Japanese Red Cross Himeji Hospital, Himeji, Japan., Iwamoto H; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, 830-0011, Japan., Rizzato MD; Oncology Unit 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Himmelsbach V; Department of Internal Medicine 1, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany., Masi G; Unit of Medical Oncology 2, University Hospital of Pisa, Pisa, Italy., Corradi M; Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy., Celsa C; Section of Gastroenterology and Hepatology, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, PROMISE, University of Palermo, Palermo, Italy., Fabio C; Department of Internal Medicine, Ospedale degli Infermi di Faenza, Faenza, Emilia Romagna, Italy., Frassineti GL; Medical Oncology Unit, IRST IRCCS, Meldola, Italy., Cascinu S; Department of Oncology, IRCCS San Raffaele Scientific Institute Hospital, Vita-Salute San Raffaele University, Milan, Italy.; Vita-Salute University San Raffaele, Milan, Italy., Casadei-Gardini A; Department of Oncology, IRCCS San Raffaele Scientific Institute Hospital, Vita-Salute San Raffaele University, Milan, Italy. casadeigardini@gmail.com.; Vita-Salute University San Raffaele, Milan, Italy. casadeigardini@gmail.com., Presa J; Liver Unit-CHTMAD, Vila Real, Portugal.

المصدر: Scientific reports [Sci Rep] 2024 Aug 30; Vol. 14 (1), pp. 20200. Date of Electronic Publication: 2024 Aug 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Metformin*/therapeutic use , Metformin*/administration & dosage , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/administration & dosage , Bevacizumab*/therapeutic use , Bevacizumab*/administration & dosage , Quinolines*/therapeutic use , Quinolines*/administration & dosage , Liver Neoplasms*/drug therapy , Liver Neoplasms*/mortality , Carcinoma, Hepatocellular*/drug therapy , Carcinoma, Hepatocellular*/mortality , Insulin*/therapeutic use , Phenylurea Compounds*/therapeutic use , Phenylurea Compounds*/administration & dosage , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/therapeutic use , Hydroxymethylglutaryl-CoA Reductase Inhibitors*/administration & dosage , Aspirin*/therapeutic use , Aspirin*/administration & dosage, Humans ; Male ; Female ; Aged ; Middle Aged ; Prognosis ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Retrospective Studies ; Aged, 80 and over

المؤلفون: Chen S; College of Chemistry and Life Science, Changchun University of Technology, Yan'an Street 2055, Changchun 130012, PR China., Jiang Y; College of Chemistry and Life Science, Changchun University of Technology, Yan'an Street 2055, Changchun 130012, PR China., Li J; College of Chemistry and Life Science, Changchun University of Technology, Yan'an Street 2055, Changchun 130012, PR China., You M; College of Chemistry and Life Science, Changchun University of Technology, Yan'an Street 2055, Changchun 130012, PR China., Zhang R; College of Chemistry and Life Science, Changchun University of Technology, Yan'an Street 2055, Changchun 130012, PR China., Li J; College of Chemistry and Life Science, Changchun University of Technology, Yan'an Street 2055, Changchun 130012, PR China., Fu Z; Sinovac Biotech Ltd, Shangdi West Road 39, Beijing 100085, PR China., Xie J; College of Chemistry and Life Science, Changchun University of Technology, Yan'an Street 2055, Changchun 130012, PR China. Electronic address: xiejiahan@ccut.edu.cn., Wang Z; College of Chemistry and Life Science, Changchun University of Technology, Yan'an Street 2055, Changchun 130012, PR China. Electronic address: wangzhibing@ccut.edu.cn.

المصدر: Food chemistry [Food Chem] 2024 Aug 30; Vol. 450, pp. 139298. Date of Electronic Publication: 2024 Apr 10.

نوع المنشور: Journal Article; Evaluation Study

بيانات الدورية: Publisher: Elsevier Applied Science Publishers Country of Publication: England NLM ID: 7702639 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7072 (Electronic) Linking ISSN: 03088146 NLM ISO Abbreviation: Food Chem Subsets: MEDLINE

مواضيع طبية MeSH: Liquid Phase Microextraction*/methods , Herbicides*/chemistry , Herbicides*/isolation & purification , Herbicides*/analysis , Milk*/chemistry , Phenylurea Compounds*/isolation & purification , Phenylurea Compounds*/chemistry , Phenylurea Compounds*/analysis , Fruit and Vegetable Juices*/analysis , Solvents*/chemistry, Animals ; Water Pollutants, Chemical/chemistry ; Water Pollutants, Chemical/isolation & purification ; Chromatography, High Pressure Liquid ; Food Contamination/analysis

المؤلفون: Wang X; Institute of Hepatobiliary Surgery, Southwest Hospital, Army Medical University, Chongqing, 400038, China., Sun X; Institute of Hepatobiliary Surgery, Southwest Hospital, Army Medical University, Chongqing, 400038, China., Lei Y; Institute of Hepatobiliary Surgery, Southwest Hospital, Army Medical University, Chongqing, 400038, China., Fang L; Department of Surgical Anesthesiology, Southwest Hospital, Army Medical University, Chongqing, 400038, China., Wang Y; Outpatient Department, Southwest Hospital, Army Medical University, Chongqing, 400038, China., Feng K; Institute of Hepatobiliary Surgery, Southwest Hospital, Army Medical University, Chongqing, 400038, China., Xia F; Institute of Hepatobiliary Surgery, Southwest Hospital, Army Medical University, Chongqing, 400038, China. frankfxia@163.com.

المصدر: BMC cancer [BMC Cancer] 2024 Aug 22; Vol. 24 (1), pp. 1036. Date of Electronic Publication: 2024 Aug 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Hepatocellular*/drug therapy , Carcinoma, Hepatocellular*/therapy , Carcinoma, Hepatocellular*/mortality , Carcinoma, Hepatocellular*/pathology , Carcinoma, Hepatocellular*/surgery , Quinolines*/therapeutic use , Quinolines*/administration & dosage , Quinolines*/adverse effects , Liver Neoplasms*/drug therapy , Liver Neoplasms*/therapy , Liver Neoplasms*/pathology , Liver Neoplasms*/surgery , Liver Neoplasms*/mortality , Phenylurea Compounds*/administration & dosage , Phenylurea Compounds*/therapeutic use , Phenylurea Compounds*/adverse effects , Radiofrequency Ablation*/methods , Radiofrequency Ablation*/adverse effects , Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects, Humans ; Male ; Female ; Middle Aged ; Aged ; Retrospective Studies ; Combined Modality Therapy ; Adult ; Treatment Outcome ; Aged, 80 and over

المؤلفون: Kawazoe A; National Cancer Center Hospital East, Kashiwa, Japan., Xu RH; Department of Medical Oncology, State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangdong, China., García-Alfonso P; Medical Oncology Service, Hospital G. U. Gregorio Marañón, IiSGM, Universidad Complutense, Madrid, Spain., Passhak M; Rambam Health Care Campus-Oncology, Haifa, Israel., Teng HW; Division of Medical Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.; National Yang Ming Chiao Tung University, Hsinchu, Taiwan., Shergill A; University of Chicago Pritzker School of Medicine, Chicago, IL., Gumus M; Istanbul Medeniyet University Hospital, Istanbul, Turkey., Qvortrup C; Righospitalet, Copenhagen, Denmark., Stintzing S; Department of Oncology, Rigshospitalet, Copenhagen, Denmark., Towns K; North York General Hospital, Toronto, ON, Canada., Kim TW; Department of Oncology, Asan Medical Center, University of Ulsan, Seoul, Republic of Korea., Shiu KK; University College Hospital, NHS Foundation Trust, London, United Kingdom., Cundom J; Instituto de Diagnóstico e Investigaciones Metabólicas, Buenos Aires, Argentina., Ananda S; Peter MacCallum Cancer Centre and Epworth Healthcare, Melbourne, VIC, Australia., Lebedinets A; Leningrad Regional Clinical Oncology Dispensary, St Petersburg, Russia., Fu R; MSD China, Shanghai, China., Jain R; Merck & Co, Inc, Rahway, NJ., Adelberg D; Merck & Co, Inc, Rahway, NJ., Heinemann V; Comprehensive Cancer Center at Ludwig Maximilian University of Munich, Munich, Germany., Yoshino T; National Cancer Center Hospital East, Kashiwa, Japan., Elez E; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain.

مؤلفون مشاركون: LEAP-017 Investigators

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Aug 20; Vol. 42 (24), pp. 2918-2927. Date of Electronic Publication: 2024 Jun 04.

نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Phenylurea Compounds*/administration & dosage , Phenylurea Compounds*/therapeutic use , Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/pathology , Colorectal Neoplasms*/mortality , Quinolines*/administration & dosage , Quinolines*/therapeutic use , Quinolines*/adverse effects , Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects, Humans ; Male ; Female ; Middle Aged ; Aged ; Standard of Care ; Adult ; Liver Neoplasms/secondary ; Liver Neoplasms/drug therapy ; Aged, 80 and over ; Pyridines

المؤلفون: Yan G; Department of Pathology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Zhengzhou Key Laboratory of Early Diagnosis for Gynecological Diseases, Zhengzhou, China., Du Y; Department of Pathology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Zhengzhou Key Laboratory of Early Diagnosis for Gynecological Diseases, Zhengzhou, China., Zhang H; Department of Pathology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Zhengzhou Key Laboratory of Early Diagnosis for Gynecological Diseases, Zhengzhou, China., Yan J; Department of Pathology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Zhengzhou Key Laboratory of Early Diagnosis for Gynecological Diseases, Zhengzhou, China., Liu Y; Department of Pathology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Zhengzhou Key Laboratory of Early Diagnosis for Gynecological Diseases, Zhengzhou, China., Ban Z; Department of Pathology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Zhengzhou Key Laboratory of Early Diagnosis for Gynecological Diseases, Zhengzhou, China., Guo YZ; Department of Pathology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Zhengzhou Key Laboratory of Early Diagnosis for Gynecological Diseases, Zhengzhou, China., Zeng X; Department of Pathology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Zhengzhou Key Laboratory of Early Diagnosis for Gynecological Diseases, Zhengzhou, China.

المصدر: Frontiers in immunology [Front Immunol] 2024 Aug 09; Vol. 15, pp. 1404669. Date of Electronic Publication: 2024 Aug 09 (Print Publication: 2024).

نوع المنشور: Meta-Analysis; Systematic Review

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized*/administration & dosage , Antibodies, Monoclonal, Humanized*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Endometrial Neoplasms*/drug therapy , Endometrial Neoplasms*/mortality , Neoplasm Recurrence, Local*/drug therapy , Phenylurea Compounds*/administration & dosage , Phenylurea Compounds*/adverse effects , Quinolines*/administration & dosage , Quinolines*/adverse effects, Female ; Humans ; Treatment Outcome

المؤلفون: Shang X; Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China., Su H; Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China., Chen X; Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China., Wang Y; Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China., Wan X; Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China., Zhang Y; Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China., Jin Y; Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China fengfz1969@sina.com jinying@pumch.cn., Feng F; Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric & Gynecologic Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China fengfz1969@sina.com jinying@pumch.cn.

المصدر: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 Aug 05; Vol. 34 (8), pp. 1203-1210. Date of Electronic Publication: 2024 Aug 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Endometrial Neoplasms*/drug therapy , Endometrial Neoplasms*/pathology , Phenylurea Compounds*/administration & dosage , Phenylurea Compounds*/adverse effects , Phenylurea Compounds*/therapeutic use , Quinolines*/administration & dosage , Quinolines*/adverse effects , Quinolines*/therapeutic use , Ovarian Neoplasms*/drug therapy , Ovarian Neoplasms*/pathology , Neoplasm Recurrence, Local*/drug therapy , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/administration & dosage, Humans ; Female ; Pilot Projects ; Middle Aged ; Aged ; Adult ; Aged, 80 and over ; Programmed Cell Death 1 Receptor/antagonists & inhibitors